BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8748050)

  • 21. [Case of malignant neuroleptic syndrome caused by an anti-depressive agent, later complicated by respiratory insufficiency and DIC].
    Okamoto K; Umeno M; Takagi H; Nagano S; Takeda Y
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):727-9. PubMed ID: 9627481
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies of risk factors and preventive care for neuroleptic malignant syndrome].
    Tanii H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):177-81. PubMed ID: 17240842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Malignant neuroleptic syndrome under metoclopramide and neuroleptics in anuria].
    Krähenbühl S; Raisin J; Herren T
    Schweiz Med Wochenschr; 1993 Jul; 123(26):1359-62. PubMed ID: 8342005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
    Tanii H; Ichihashi K; Inoue K; Fujita K; Okazaki Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1176-8. PubMed ID: 16720068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD; Pedersen S
    Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic malignant syndrome in Mexico.
    Montoya A; Ocampo M; Torres-Ruiz A
    Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin syndrome.
    Mills KC
    Am Fam Physician; 1995 Oct; 52(5):1475-82. PubMed ID: 7572570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxin-induced hyperthermic syndromes.
    Rusyniak DE; Sprague JE
    Med Clin North Am; 2005 Nov; 89(6):1277-96. PubMed ID: 16227063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amitriptyline: initial intolerance and subsequent psychosis.
    O'Connel GJ; Campbell PB; Anath JV
    Can Med Assoc J; 1972 Jan; 106(2):115. PubMed ID: 5058883
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neuroleptic malignant syndrome-dopamine-serotonin syndrome--the physiopathology, diagnosis, and therapy].
    Naito Y
    Seishin Shinkeigaku Zasshi; 1997; 99(10):803-8. PubMed ID: 9465737
    [No Abstract]   [Full Text] [Related]  

  • 32. Carbamazepine in the treatment of neuroleptic malignant syndrome.
    Thomas P; Maron M; Rascle C; Cottencin O; Vaiva G; Goudemand M
    Biol Psychiatry; 1998 Feb; 43(4):303-5. PubMed ID: 9513741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome, amitriptyline, and thioridazine.
    Corrigan FM; Coulter F
    Biol Psychiatry; 1988 Feb; 23(3):320-1. PubMed ID: 3337866
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pharmacological study of veratrine-induced hyperthermia in the rat: a model of neuroleptic malignant syndrome.
    Kato T; Yamawaki S
    Hiroshima J Med Sci; 1989 Dec; 38(4):173-81. PubMed ID: 2637245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy.
    Tsuchiya N; Morimura E; Hanafusa T; Shinomura T
    Paediatr Anaesth; 2007 Mar; 17(3):281-4. PubMed ID: 17263746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
    Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine and neuroleptic malignant syndrome.
    Halman M; Goldbloom DS
    Biol Psychiatry; 1990 Sep; 28(6):518-21. PubMed ID: 2223920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome.
    Waldorf S
    AANA J; 2003 Oct; 71(5):389-94. PubMed ID: 14625976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withdrawal NMS after drug treatment.
    Merriam AE
    Biol Psychiatry; 1988 Jul; 24(3):368-9. PubMed ID: 3401532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.